Burning Rock Biotech (BNR) Assets Average (2020 - 2026)

Burning Rock Biotech (BNR) has reported Assets Average for 7 consecutive years, with $114.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets Average fell 4.63% year-over-year to $114.9 million; the TTM figure through Mar 2026 stood at $114.9 million (down 4.63% YoY), while the FY2025 annual figure was $119.3 million, down 10.89% from the prior year.
• Assets Average came in at $114.9 million for Q1 2026 at Burning Rock Biotech, roughly flat from $114.9 million in the prior quarter.
• The five-year high for Assets Average was $344.4 million in Q1 2022, with the low at $114.6 million in Q3 2025.
• Average Assets Average over 5 years is $177.1 million, with a median of $140.6 million recorded in 2024.
• Across the five-year window, Assets Average sank 37.64% in 2023 and declined 4.63% in 2026, its largest moves.
• Year by year, Assets Average stood at $233.3 million in 2022, then slumped by 34.77% to $152.2 million in 2023, then declined by 13.4% to $131.8 million in 2024, then decreased by 12.83% to $114.9 million in 2025, then grew by 0.05% to $114.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $114.9 million, $114.9 million, and $114.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.